HIGHLIGHTS
- who: Dravet syndrome. Lennox Gastaut and collaborators from the (UNIVERSITY) have published the Article: Use of cannabidiol in the treatment of epilepsy: Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex, in the Journal: (JOURNAL)
- what: The aim of this study was to assess the efficacy, safety, and short- and long-term tolerability of CBD, as an adjuvant treatment in children and adults with inadequately controlled DS, LGS, or TSC. This systematic review will be carried out in accordance with Preferred Reporting Items for Systematic reviews and MetaAnalyses (PRISMA)12. This analysis demonstrated increase in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.